1. Home
  2. TRLV vs AVLN Comparison

TRLV vs AVLN Comparison

Compare TRLV & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trulieve Cannabis Corp. Subordinate Voting Shares

TRLV

Trulieve Cannabis Corp. Subordinate Voting Shares

HOLD

Current Price

$9.95

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

BUY

Current Price

$23.96

Market Cap

1.3B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TRLV
AVLN
Founded
1940
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.3B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
TRLV
AVLN
Price
$9.95
$23.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$18.18
★ $61.80
AVG Volume (30 Days)
★ 2.1M
290.3K
Earning Date
11-05-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 26.58
N/A
EPS
★ N/A
N/A
Revenue
★ $1,181,180,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.82
$22.68
52 Week High
$12.93
$40.17

Technical Indicators

Market Signals
Indicator
TRLV
AVLN
Relative Strength Index (RSI) 36.82 30.78
Support Level $7.82 N/A
Resistance Level $10.15 $30.45
Average True Range (ATR) 0.55 1.56
MACD -0.16 -0.12
Stochastic Oscillator 3.59 20.25

Price Performance

Historical Comparison
TRLV
AVLN

About TRLV Trulieve Cannabis Corp. Subordinate Voting Shares

Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: